Every one of those 2 sits in a single category, market-trends. National Board of Pharmaceuticals and Poisons is most often covered alongside India, which appears in 2 of these 2 stories. Across an 18-day span, the pace is roughly 0.8 stories per week.
Recent coverage · National Board of Pharmaceuticals and Poisons
↑
2stories
avg impact
0%positive
0%negative
100% neutral
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about National Board of Pharmaceuticals and Poisons
Every one of those 2 sits in a single category, market-trends. National Board of Pharmaceuticals and Poisons is most often covered alongside India, which appears in 2 of these 2 stories. Across an 18-day span, the pace is roughly 0.8 stories per week. Their average consequence score of 5.5 runs below the beat's 6.5 for that window. They are less corroborated than the beat average, carrying 3 original sources each against 5.1 for the same window. National Board of Pharmaceuticals and Poisons appears in 2 tracked Healthcare stories published from July 11, 2026 through July 28, 2026.
Stories tracked
2
Per week
0.8
Sources per story
3
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 151 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering National Board of Pharmaceuticals and Poisons. Shared-story counts are live from our verified record — not editorial picks.
Post-war Sudan is targeting Indian healthcare investment to rebuild hospitals, supply chains, and pharmaceutical access, with Indian medicines already dominating imports. A high-level roundtable signals government support and regulatory engagement.
Sudan's appeal for Indian healthcare investment beyond pharma offers a vast opportunity for health IT, medical devices, and hospital infrastructure, underscored by India's 51% share of medicine imports. The roundtable signals a shift from aid to commercial partnership in rebuilding a war-torn health system.
National Board of Pharmaceuticals and Poisons is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.